We are live on ! Find out more
BG

Bahl & Gaynor Portfolio holdings

AUM $19.8B
1-Year Est. Return 19.53%
This Fund
S&P 500
This Quarter Est. Return
-2.99%
1 Year Est. Return
+19.53%
3 Year Est. Return
+63.97%
5 Year Est. Return
+84.2%
10 Year Est. Return
+296.44%
AUM
$15.7B
AUM Growth
-$771M
Cap. Flow
-$113M
Cap. Flow %
-0.72%
Top 10 Hldgs %
31.42%
Holding
351
New
7
Increased
123
Reduced
167
Closed
25

Top Sells

Rank Stock Value
1
TFC icon
Truist Financial
TFC
+$186M
2
CCI icon
Crown Castle
CCI
+$89.7M
3
AVGO icon
Broadcom
AVGO
+$80.5M
4
ABT icon
Abbott
ABT
+$45.5M
5
QCOM icon
Qualcomm
QCOM
+$27.4M

Sector Composition

Rank Sector Weight
1 Technology 21.48%
2 Healthcare 14.72%
3 Consumer Staples 12.24%
4 Financials 12.18%
5 Industrials 11.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PM icon
201
Philip Morris
PM
$295B
$1.95M 0.01%
21,091
-767
-4% -$73.8K
KMB icon
202
Kimberly-Clark
KMB
$36.5B
$1.95M 0.01%
16,152
-551
-3% -$71.2K
BWXT icon
203
BWX Technologies
BWXT
$15.6B
$1.94M 0.01%
25,920
+2,531
+11% +$183K
TFC icon
204
Truist Financial
TFC
$64B
$1.91M 0.01%
66,817
-6,053,981
-99% -$186M
STE icon
205
Steris
STE
$23.1B
$1.91M 0.01%
8,703
-362
-4% -$81.9K
DEO icon
206
Diageo
DEO
$53.6B
$1.9M 0.01%
12,762
-950
-7% -$159K
HMN icon
207
Horace Mann Educators
HMN
$2.11B
$1.88M 0.01%
64,072
-229,008
-78% -$6.65M
NSC icon
208
Norfolk Southern
NSC
$75.1B
$1.86M 0.01%
9,460
+168
+2% +$36.3K
SCL icon
209
Stepan Co
SCL
$1.48B
$1.84M 0.01%
24,478
-358
-1% -$31.3K
WPC icon
210
W.P. Carey
WPC
$16.4B
$1.72M 0.01%
32,423
-8,207
-20% -$526K
TMO icon
211
Thermo Fisher Scientific
TMO
$220B
$1.7M 0.01%
3,366
+156
+5% +$83.1K
VWO icon
212
Vanguard FTSE Emerging Markets ETF
VWO
$124B
$1.65M 0.01%
41,954
-6,011
-13% -$245K
DHI icon
213
D.R. Horton
DHI
$42.3B
$1.64M 0.01%
15,295
-921
-6% -$110K
PRGS icon
214
Progress Software
PRGS
$1.76B
$1.57M 0.01%
29,824
-10,127
-25% -$593K
NVDA icon
215
NVIDIA
NVDA
$5.42T
$1.57M 0.01%
36,030
-60
-0.2% -$2.69K
AIT icon
216
Applied Industrial Technologies
AIT
$13.3B
$1.55M 0.01%
10,000
CNMD icon
217
CONMED
CNMD
$1.47B
$1.54M 0.01%
15,227
+12
+0.1% +$1.38K
CL icon
218
Colgate-Palmolive
CL
$74.4B
$1.49M 0.01%
20,978
-9
-0% -$673
SJM icon
219
J.M. Smucker
SJM
$12.8B
$1.46M 0.01%
11,884
GIS icon
220
General Mills
GIS
$19.7B
$1.45M 0.01%
22,587
-1,136
-5% -$80.3K
CSX icon
221
CSX Corp
CSX
$93.1B
$1.29M 0.01%
42,074
-628
-1% -$19.9K
COHR icon
222
Coherent
COHR
$74.2B
$1.27M 0.01%
38,929
-180
-0.5% -$7.39K
BF.B icon
223
Brown-Forman Class B
BF.B
$13.1B
$1.27M 0.01%
22,000
-173
-0.8% -$11.5K
VIGI icon
224
Vanguard International Dividend Appreciation ETF
VIGI
$9.3B
$1.25M 0.01%
17,520
+750
+4% +$55.8K
EHC icon
225
Encompass Health
EHC
$12.4B
$1.25M 0.01%
18,553
-258
-1% -$17.7K

Similar funds

Bahl & Gaynor's Q3 2023 Portfolio in Review

As of Q3 2023, Bahl & Gaynor held 351 positions worth $15.7B, down 4.7% from $16.4B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Bahl & Gaynor's Q3 2023 filing shows 7 new, 123 increased, 167 reduced and 25 closed positions. Its largest new stake was NXP Semiconductors: 296,482 shares worth $59.3M. The largest sale was Truist Financial, an estimated $186M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Bahl & Gaynor's largest Q3 2023 buy was NXP Semiconductors: 296,482 shares worth $59.3M.
  • Bahl & Gaynor added most to Williams Companies in Q3 2023, an estimated $69.7M increase.
  • Bahl & Gaynor's biggest Q3 2023 reduction was Truist Financial, cutting an estimated $186M.
  • Bahl & Gaynor fully exited Brunswick in Q3 2023, selling an estimated $8.74M.
  • Bahl & Gaynor's ten largest holdings make up 31% of its $15.7B portfolio in Q3 2023.
  • Bahl & Gaynor opened 7 new positions and closed 25 in Q3 2023.
  • Bahl & Gaynor's portfolio value fell 4.7% quarter-over-quarter to $15.7B.

Based on Bahl & Gaynor's 13F filing for Q3 2023, filed 3 Nov 2023.